JP2001525325A5 - - Google Patents

Download PDF

Info

Publication number
JP2001525325A5
JP2001525325A5 JP2000523217A JP2000523217A JP2001525325A5 JP 2001525325 A5 JP2001525325 A5 JP 2001525325A5 JP 2000523217 A JP2000523217 A JP 2000523217A JP 2000523217 A JP2000523217 A JP 2000523217A JP 2001525325 A5 JP2001525325 A5 JP 2001525325A5
Authority
JP
Japan
Prior art keywords
benzothieno
pyrimidin
tetrahydro
chloro
ethanolamine salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000523217A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001525325A (ja
JP4314341B2 (ja
Filing date
Publication date
Priority claimed from DE19752952A external-priority patent/DE19752952A1/de
Application filed filed Critical
Publication of JP2001525325A publication Critical patent/JP2001525325A/ja
Publication of JP2001525325A5 publication Critical patent/JP2001525325A5/ja
Application granted granted Critical
Publication of JP4314341B2 publication Critical patent/JP4314341B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000523217A 1997-11-28 1998-11-19 チエノピリミジン類 Expired - Fee Related JP4314341B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19752952A DE19752952A1 (de) 1997-11-28 1997-11-28 Thienopyrimidine
DE19752952.6 1997-11-28
PCT/EP1998/007436 WO1999028325A1 (de) 1997-11-28 1998-11-19 Thienopyrimidine

Publications (3)

Publication Number Publication Date
JP2001525325A JP2001525325A (ja) 2001-12-11
JP2001525325A5 true JP2001525325A5 (https=) 2008-12-18
JP4314341B2 JP4314341B2 (ja) 2009-08-12

Family

ID=7850200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000523217A Expired - Fee Related JP4314341B2 (ja) 1997-11-28 1998-11-19 チエノピリミジン類

Country Status (24)

Country Link
US (2) US6420368B1 (https=)
EP (1) EP1036078B1 (https=)
JP (1) JP4314341B2 (https=)
KR (1) KR20010032445A (https=)
CN (1) CN1138780C (https=)
AR (1) AR010962A1 (https=)
AT (1) ATE361926T1 (https=)
AU (1) AU742433B2 (https=)
BR (1) BR9815409A (https=)
CA (1) CA2311922C (https=)
CO (1) CO4980884A1 (https=)
CZ (1) CZ291068B6 (https=)
DE (2) DE19752952A1 (https=)
ES (1) ES2285796T3 (https=)
HK (1) HK1038924A1 (https=)
HU (1) HUP0100488A3 (https=)
ID (1) ID24571A (https=)
NO (1) NO20002702D0 (https=)
PL (1) PL341156A1 (https=)
RU (1) RU2217431C2 (https=)
SK (1) SK7772000A3 (https=)
TW (1) TW472059B (https=)
WO (1) WO1999028325A1 (https=)
ZA (1) ZA9810845B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
CN1346358A (zh) 1999-03-30 2002-04-24 日本曹达株式会社 噻吩并嘧啶化合物及其盐和制备方法
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
US20020006926A1 (en) 2000-04-19 2002-01-17 Roylance H. H. Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of parkinson's disease
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10042997A1 (de) * 2000-09-01 2002-03-14 Merck Patent Gmbh Thienopyrimidine
CA2423981A1 (en) * 2000-09-29 2003-03-28 Kimiko Ichikawa Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
AU2002227957A1 (en) * 2000-12-19 2002-07-01 Merck Patent Gmbh Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
DE10064994A1 (de) * 2000-12-23 2002-07-04 Merck Patent Gmbh Sulfamidothienopyrimidine
DE10103647A1 (de) 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
HUP0302987A2 (hu) * 2001-01-31 2003-12-29 Merck Patent Gmbh Pirazolo [4,3-d] pirimidinszármazékokat vagy tienopirimidinszármazékokat és nitrátvegyületeket tartalmazó gyógyászati készítmények
MXPA03009925A (es) * 2001-04-30 2004-06-30 Bayer Pharmaceuticals Corp Nuevas tiofeno [2,3-d]pirimidinas 4-amino-5,6-sustituidas.
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
OA13050A (en) 2003-04-29 2006-11-10 Pfizer Ltd 5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension.
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
CA2562251C (en) 2004-04-07 2009-04-28 Pfizer Inc. Pyrazolo'4,3-d pyrimidines
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
ES2259891B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ES2259892B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
AR088218A1 (es) 2011-07-19 2014-05-21 Infinity Pharmaceuticals Inc Compuestos heterociclicos utiles como inhibidores de pi3k
CN109297923A (zh) * 2018-09-19 2019-02-01 南通出入境检验检疫局检验检疫综合技术中心 纺织品中微量含氟整理剂的测定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE245666C (https=)
DD245666A1 (de) * 1985-09-20 1987-05-13 Univ Halle Wittenberg Verfahren zur herstellung von 4-aminosubstituierten thieno 2,3-d-pyrimidin-2-ylessigsaeureestern
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine

Similar Documents

Publication Publication Date Title
JP2001525325A5 (https=)
IL287708A (en) Janus kinase inhibitor salts
CA2379560A1 (en) Purine derivatives inhibitors of tyrosine protein kinase syk
TWI365188B (en) Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
AU6890800A (en) A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-D]- pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
PL1611144T3 (pl) Pochodne kwasu 2-(8,9-diokso-2,6-diazabicyklo(5.2.0)non-1(7)-en-2-ylo)alkilofosfonowego i ich zastosowanie jako antagonistów receptora N-metylo-D-asparaginianu (NMDA)
HK1049158A1 (zh) 药物活性异二氢吲衍生物
ME02688B (me) Hinazolinoni kao inhibitori humane fosfatidilinozitol 3 - kinaze delta
DK1210068T3 (da) Anvendelse af simple aminosyrer til dannelse af poröse partikler
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
CY2017011I1 (el) 2-(ΠΥΡΙΔΙΝ-2-ΥΛΑΜΙΝΟ)-ΠΥΡΙΔΟ[2,3-d]ΠΥΡΙΜΙΔΥΝ-7-ΟΝΕΣ
IL148422A0 (en) Oral dosage forms
WO2003053142A3 (en) Highly crosslinked biocidal polystyrene hydantoin particles
NZ336001A (en) Sustained release formulation comprising nefazodone
JP2005508955A5 (https=)
WO2003099265A3 (de) Pharmazeutische wirkstoffkombination sowie deren verwendung
JP2002513761A5 (https=)
JP2003252619A5 (https=)
CO5200845A1 (es) Derivados del acido monociclico 4-fenilbutanoico como antagonista del receptor vitronectina
ATE425976T1 (de) Pyrido[2,3-d]pyrimidin-7-carbonsaurederivate, deren herstellung und deren verwendung als pharmazeutische mittel
JP2004505083A5 (https=)
AU2002214422A1 (en) New use of 2-(4-isobutylphenyl)propionic acid
AU2003257797A1 (en) The salts of the quinuclidine derivatives and the preparation and applications thereof
JP2004525959A5 (https=)
ITRM20010753A1 (it) Procedimento per la preparazione di manufatti di titanio rivestito con uno strato spesso di anatasio, manufatti cosi' ottenibili, e loro uso